These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5467019)

  • 1. Sustained release hormonal preparations. 5. Absorption of 6-methyl-17-alpha-acetoxypregna-4,6-diene-3,20-dione from polydimethylsiloxane implants in vivo.
    Benagiano G; Ermini M; Chang CC; Sundaram K; Kincl FA
    Acta Endocrinol (Copenh); 1970 Jan; 63(1):29-38. PubMed ID: 5467019
    [No Abstract]   [Full Text] [Related]  

  • 2. Sustained release hormonal preparations. 9. Plasma levels and accumulation into various tissues of 6-methyl-17 alpha-acetoxy-4,6-pregnadiene-3,20-dione after oral administration or absorption from polydimethylsiloxane implants.
    Kincl FA; Angee I; Chang CC; Rudel HW
    Acta Endocrinol (Copenh); 1970 Jul; 64(3):508-18. PubMed ID: 4916445
    [No Abstract]   [Full Text] [Related]  

  • 3. Excretion of [6-14C]megestrol acetate (6 methyl-17 acetoxypregna-4,6 diene, 3,20 dione) released from subcutaneous silastic implants in women.
    Coutinho EM; Ferreira DA; Prates H; Kincl F
    J Reprod Fertil; 1970 Nov; 23(2):345-7. PubMed ID: 5481731
    [No Abstract]   [Full Text] [Related]  

  • 4. Sustained release hormonal preparations. 12. Plasma levels of 6-methyl-17-alpha-acetozy-4,6-pregnadiene-3,20-dione in hamsters.
    Zbuzkova V; Kincl FA
    Steroids; 1970 Oct; 16(4):447-50. PubMed ID: 5503549
    [No Abstract]   [Full Text] [Related]  

  • 5. Sustained release hormonal preparations. 3. Biological effectivness of 6-methyl-17-alpha-acetoxypregna-4,6-diene-3,20-dione.
    Chang CC; Kincl FA
    Steroids; 1968 Dec; 12(6):689-96. PubMed ID: 5726404
    [No Abstract]   [Full Text] [Related]  

  • 6. Sustained release hormonal preparations. 8. Diffusion of various steroids from cholesterol pellets.
    Kincl FA; Sundaram K; Chang CC; Rudel HW
    Acta Endocrinol (Copenh); 1970 Jun; 64(2):253-64. PubMed ID: 5468367
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on sustained contraceptive effects with subcutaneous polydimethylsiloxane implants. 1. Diffusion of megestrol acetate in humans.
    Benagiano G; Ermini M; Carenza L; Rolfini G
    Acta Endocrinol (Copenh); 1973 Jun; 73(2):335-46. PubMed ID: 4740833
    [No Abstract]   [Full Text] [Related]  

  • 8. [Local factors influencing in-vivo diffusion of steroid hormones enclosed in polydimethylsiloxane (PDS) capsules].
    Ermini M; Carpino F; Russo M; Benagiano G
    Boll Soc Ital Biol Sper; 1972 Aug; 48(15):408-10. PubMed ID: 4644477
    [No Abstract]   [Full Text] [Related]  

  • 9. Sustained release hormonal preparations. 12. Plasma levels of 6-methyl-17-alpha-acetoxy-4,6-pregnadiene-3,20-dione in hamsters.
    Zbuzkova V; Kincl FA
    Steroids; 1970 Oct; 16(4):447-50. PubMed ID: 5496444
    [No Abstract]   [Full Text] [Related]  

  • 10. Sustained release hormonal preparations. 11. Biological effectiveness of (DL)-13 -ethyl-17 -ethynyl-17 -hydroxy-4-gonen-3-one released from polydimethylsiloxane capsules.
    Zbuzková V; Kincl FA
    Endocrinol Exp; 1970; 4(4):215-20. PubMed ID: 5317371
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on physiology & biochemistry of cervix: response of rat cervix to a continuous low dose of megestrol acetate.
    Sanwal PC; Mehrotra PK; Karkun JN; Dasgupta PR; Kar AB
    Indian J Exp Biol; 1970 Oct; 8(4):326-7. PubMed ID: 5533834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous steroid treatment by subdermal polysiloxane implants.
    Benagiano G; Ermini M
    Acta Eur Fertil; 1972 Jun; 3(2):119-30. PubMed ID: 4606384
    [No Abstract]   [Full Text] [Related]  

  • 13. [Oral treatment of prolonged dysfunctional bleedings with estrogen-gestagen preparations].
    Rehsteiner HP
    Zentralbl Gynakol; 1969 Feb; 91(6):178-86. PubMed ID: 5405176
    [No Abstract]   [Full Text] [Related]  

  • 14. [Control of fertility using micro-doses of megestrol acetate].
    Avendaño S
    Rev Chil Obstet Ginecol; 1969; 33(4):238-52. PubMed ID: 5355547
    [No Abstract]   [Full Text] [Related]  

  • 15. Sustained release hormonal preparation. 4. Biologic effectiveness of steroid hormones.
    Chang CC; Kincl FA
    Fertil Steril; 1970 Feb; 21(2):134-9. PubMed ID: 5461141
    [No Abstract]   [Full Text] [Related]  

  • 16. Estrus control in swine through management and by the oral administration of megestrol acetate.
    Norrish JG; Burgess TD
    Can Vet J; 1968 May; 9(5):116-9. PubMed ID: 5689809
    [No Abstract]   [Full Text] [Related]  

  • 17. Fertility control in women with a progestogen released in microquantities from subcutaneous capsules.
    Croxatto H; Díaz S; Vera R; Etchart M; Atria P
    Am J Obstet Gynecol; 1969 Dec; 105(7):1135-8. PubMed ID: 5352594
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experience with a sequential oral contraceptive].
    Buus JG
    Ugeskr Laeger; 1970 Dec; 132(52):2477-80. PubMed ID: 5491497
    [No Abstract]   [Full Text] [Related]  

  • 19. Acceptability of long-term contraceptive steroid administration in humans by subcutaneous Silastic capsules.
    Tatum HJ; Coutinho EM; Filho JA; Sant'anna AR
    Am J Obstet Gynecol; 1969 Dec; 105(7):1139-43. PubMed ID: 5352595
    [No Abstract]   [Full Text] [Related]  

  • 20. Preliminary experiences with a sequential preparation in the treatment of menopausal complaints.
    Schellen AM; Branolte JH
    Bull Soc R Belge Gynecol Obstet; 1969; 39(3):203-9. PubMed ID: 5399681
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.